Skip to content
Screener

Cencora COR Q4 2025 Annual earnings

Reported November 5, 2025 · Before market open

Revenue$83.7BBeat by $270.3M
EPS$3.84Beat by $0.05
Revenue estimate$83.5B
EPS estimate$3.79

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$88.1B
EPS estimate$4.51

Financials

Q4 2025

Income statement

See full
Revenue$83.7B+5.9%
Gross profit$3.0B+18.5%
Operating income$18.5M-85.4%

Balance sheet

See full
Cash & equivalents$4.4B+39.1%
Total debt$9.3B+84.9%
Total equity$1.5B+133%
Total assets$76.6B+14.1%

Cash flow

See full
Operating cash flow$3.1B+213%
CapEx$249.8M+37.0%
Free cash flow$2.9B+252%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$60.59B+37.3%
Enterprise value$65.57B+42.4%
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%+0.2pp
Operating margin0.8%+0.1pp
FCF margin1%0.0pp

Returns & leverage

See full
Debt / equity6.2×-1.6×
Current ratio0.9×0.0×

Segments

By segment

See full
U.S. Healthcare Solutions$80.3B+12.0%
International Healthcare Solutions$9.5B+28.1%

FAQ

When did Cencora report Q4 2025 earnings?
Cencora (COR) reported Q4 2025 earnings on November 5, 2025 before market open.
What were Cencora's Q4 2025 revenue and EPS?
Cencora reported revenue of $83.7B and eps of $3.84 for Q4 2025.
Did Cencora beat estimates in Q4 2025?
Revenue beat the consensus estimate of $83.5B by $270.3M. EPS beat the consensus estimate of $3.79 by $0.05.
How did Cencora's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.9% from $79.1B a year earlier and eps grew 15.0% from $3.34.
Where can I find Cencora's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001140859-25-000128) and the 10-K periodic report (0001140859-25-000131) directly on SEC EDGAR. The filing index links above go to sec.gov.